IT8421436A0 - Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la - Google Patents

Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la

Info

Publication number
IT8421436A0
IT8421436A0 IT8421436A IT2143684A IT8421436A0 IT 8421436 A0 IT8421436 A0 IT 8421436A0 IT 8421436 A IT8421436 A IT 8421436A IT 2143684 A IT2143684 A IT 2143684A IT 8421436 A0 IT8421436 A0 IT 8421436A0
Authority
IT
Italy
Prior art keywords
protein
polideoxyribonucleotide
segment
produce
produced
Prior art date
Application number
IT8421436A
Other languages
English (en)
Other versions
IT1175508B (it
IT8421436A1 (it
Inventor
Annette Elmblad
Gunnar Palm
Staffan Josephson
Larl Olof Heden
Erik Holmgren
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Publication of IT8421436A0 publication Critical patent/IT8421436A0/it
Publication of IT8421436A1 publication Critical patent/IT8421436A1/it
Application granted granted Critical
Publication of IT1175508B publication Critical patent/IT1175508B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
IT21436/84A 1983-06-23 1984-06-15 Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta IT1175508B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8303626A SE8303626D0 (sv) 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced

Publications (3)

Publication Number Publication Date
IT8421436A0 true IT8421436A0 (it) 1984-06-15
IT8421436A1 IT8421436A1 (it) 1985-12-15
IT1175508B IT1175508B (it) 1987-07-01

Family

ID=20351747

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21436/84A IT1175508B (it) 1983-06-23 1984-06-15 Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta

Country Status (5)

Country Link
EP (1) EP0130166A1 (it)
JP (1) JPS6019493A (it)
GB (1) GB2142033A (it)
IT (1) IT1175508B (it)
SE (1) SE8303626D0 (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
GB8522977D0 (en) * 1985-09-17 1985-10-23 Fujisawa Pharmaceutical Co Production of insulin-like growth factor 1
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
GB8507833D0 (en) * 1985-03-26 1985-05-01 Biogen Nv Production of human somatomedin c
EP0219814B1 (en) * 1985-10-21 1991-09-11 Fujisawa Pharmaceutical Co., Ltd. Process for production of isulin-like growth factor i and plasmid for production thereof
JPH0817708B2 (ja) * 1986-10-09 1996-02-28 藤沢薬品工業株式会社 Ｍｅｔ−インスリン様成長因子Ｉの発現ベクター
JPH03505966A (ja) * 1988-07-14 1991-12-26 ベイラー カレッジ オブ メディシン 生物高分子の固相組立及び再構築方法
DE69028725T2 (de) * 1989-02-28 1997-03-13 Canon Kk Partiell doppelsträngiges Oligonukleotid und Verfahren zu seiner Bildung
JP2682738B2 (ja) * 1989-06-09 1997-11-26 グロペップ プロプライエタリー リミテッド 成長ホルモン融合蛋白質
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993019084A1 (en) * 1992-03-24 1993-09-30 Synergen, Inc. Refolding and purification of insulin-like growth factor i
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
CA2341896A1 (en) 1998-08-28 2000-03-09 Febit Ferrarius Biotechnology Gmbh Support for a method for determining an analyte and a method for producing the support
EP2175021B1 (de) * 1999-02-19 2013-06-19 Synthetic Genomics, Inc. Verfahren zur Herstellung von Polymeren
EP1879624B1 (en) 2005-05-02 2011-09-21 Genzyme Corporation Gene therapy for neurometabolic disorders
PL1879623T3 (pl) 2005-05-02 2013-03-29 Genzyme Corp Terapia genowa zaburzeń rdzenia kręgowego
AR059089A1 (es) 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
AR059088A1 (es) * 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una proteina para esclerosis lateral amiotrofica
DK1988823T3 (en) 2006-02-09 2018-12-03 Genzyme Corp SLOW INTRAVENTRICULAR ADMINISTRATION
WO2007146046A2 (en) 2006-06-07 2007-12-21 Genzyme Corporation Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
PL2066791T3 (pl) 2006-10-03 2013-02-28 Genzyme Corp Terapia Genowa do leczenia stwardnienia zanikowego bocznego i innych zaburzeń rdzenia kręgowego

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201918A (en) * 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone

Also Published As

Publication number Publication date
IT1175508B (it) 1987-07-01
SE8303626D0 (sv) 1983-06-23
GB8416007D0 (en) 1984-07-25
EP0130166A1 (en) 1985-01-02
IT8421436A1 (it) 1985-12-15
JPS6019493A (ja) 1985-01-31
GB2142033A (en) 1985-01-09

Similar Documents

Publication Publication Date Title
IT8421436A0 (it) Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la
FI861210A7 (fi) N,n'-dialkylguanidinodipeptider.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK151985A (da) Humant fysiologisk aktivt polypeptid
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
ZA849221B (en) Highyl purified protein,production and use thereof
IT8521468A0 (it) Procedimento per ottenere interferon leucocitario alfa-2dell'uomo.
ES510078A0 (es) "perfeccionamientos en pulverizadores ultrasonicos".
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
FI853648A7 (fi) Menetelmä farmaseuttisesti aktiivisten 4,5-dihydro-4-okso-2-/ (2-trans-fenyylisyklopropyyli)amino/ -3-furaanikarboksyylihappojen ja niiden johdannaisten valmistamiseksi.
IT8521807A0 (it) Ultrasuoni. iniziatore di prossimita' ad
DE58902491D1 (de) Neue difluormethyl-thiadiazolyl-oxyessigsaeureamiden.
IT8422033A0 (it) Particolarmente prodotti stampati, procedimento e dispositivo per emessi continuativamente, l'accumulo di prodotti, particolarmente in formazione a squame.
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
IT8147715A0 (it) Gene vettore ricombinante cellula eloro procedimenti di produzione per preparare una proteina assomigliante ad interferone umano
DE3481420D1 (de) Physiologisch aktives proteinmaterial.
AU8589382A (en) Biologically active peptides
IT8221091A0 (it) Procedimento e dispositivo per consentire ad un automobilista di orientarsi, specialmente in una citta'.
DE3869939D1 (de) Biologisch wirksame peptide.
IT1188646B (it) Tripeptide ad attivita' immunostimolante
EP0674658A4 (en) A novel protein tyrosine kinase.
IT8620828A0 (it) Procedimento per la produzione di una l-aspartil-l-fenilalanina n-protetta.
DE3782199D1 (de) Biologisch aktive peptide tan-866.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970628